Oral Lichen Planus Clinical Trial
Official title:
Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on the Duration and Symptoms of Lesions That Caused by Symptomatic Oral Lichen Planus
Introduction :Oral lichen planus (OLP) is one of the most common disorders of the oral
cavity which is basically a chronic and inflammated mucocutaneous .There is no cure for OLP
currently. The main focus of treatment is to reduce the duration and severity of the
symptoms. This study was designed to determine and compare the parameters of improvement in
patient symptoms and lesions caused by oral lichen planus by using triamcinolone acetonide
mucoadhesive film and licorice mucoadhesive film.
Methods and materials :The study was randomized by double-blind clinical trial . Patients
with symptomatic OLP who referred to the Oral Medicine School of Dentistryin Medical
Sciences in Isfahan University participated voluntarily. The patients were divided into two
groups that were including 30 samples in each group. The first group was treated with
triamcinolone mucoadhesive film and the second group were treated with licorice mucoadhesive
film. Data were analyzed by using the Mann-Whitney test and t-test in SPSS software.
Introduction OLP is a chronic and inflammatory disease that frequently involves the oral
mucosa. Clinical symptoms of OLP are various from white keratotic lesions without pain to
erosion and painful injury (1). OLP episodic symptoms range from pain and irritation of the
mouth that can affect the normal function and causes physical and mental pressure to
patients.OLP can be seen in two main forms of reticular and erosive. Erosive OLP have been
seen as injured Arytmatozo that enclosed by keratotic striae .These lesions are often follow
by episodic symptoms of pain and irritation to severe discomfort and can cause a major
negative impact on performance of oral system and l quality of life .So, being aware of the
Clinical symptoms and management of these lesions are very important for the clinician.
(4,3,2,1)
Although, these lesions rarely are life-threatening , discomfort and pain associated with
abnormal caloric intake lead to nervosa, dehydrated in short order and malnutrition. It also
increases the risk of infection and reduce the quality of life in patients greatly.(2,3).
The main treatment for symptomatic OLP is prescribing systemic or topical corticosteroids .
(1,3) and its strong type like triamcinolone has been increasingly used in the treatment of
OLP (4).
Lichen planus is a chronic mucocutaneous disease and relatively common in middle-aged that
affected 2- 0.2% of the population. Men and women are almost equally affected. In the mouth,
white bilatera lesions sometimes cause wound The most common clinical pattern is linear
(9-5) .There is a limited study in the frequency and clinical forms of OLP.
It can be mention to Esmaeili etal study that patients in men and in fourth decades is most
common and Hypertrophic and classic type are more and the type of reticular in oral lesions
is more prevalent (10)and in another study by Khalili etal reported that the most common
form of clinical lesion is ulcerated lesion and the average time spend 18.4 months, most
commonly involving mucosa is the buccal and then the tongue and gums .White spots, lines
Wickham and mucosal erythema are the most common clinical features of the lesion (11).
There is currently no cure for OLP. The main focus of treatment is to reduce the duration
and severity of symptoms. The most common and acceptable treatment for symptomatic OLP
lesions and systemic corticosteroids or topical is to modulate the host immune response .In
mild to moderate lesions the main treatment is by topical corticosteroids such as clobetasol
gel, betamethasone gel and triamcinolone ointment (2, 3, 12). Due to the persistence of the
drug at the site of the lesion may be used new dosage form of mucoadhesive such as tablets
or film. Films are from mucoadhesive drug delivery systems that have been used in the
manufacture of mucoadhesive polymers and have received considerable attention in recent
years .The films can be attached on the oral wound healing and cause to reduce pain and
inflammatory diseases. (4, 13)
The Licorice plant have been used in traditional medicine for the treatment of aphthous
ulcers, gastric ulcers, hepatitis C, cough, Asthma, Addison and skin diseases. Clinical
pharmacology studies have shown that this herb also contains beneficial anti-inflammatory
components, antiviral and antibacterial, antioxidant, anticancer and modifying the immune
system is .Licorice contains a provision, glycyrrhetinic acid and glycyrrhizin which helps
in healing wounds (14,15,16) In 2008, Martin et al. examined the effects of oral patch
containing licorice extract (Licorice) for the treatment of aphthous ulcers and found
positive effects on the size of the lesion and the patient's report of pain. (15) Chan et
al., investigated palliative treatment of patients with symptomatic OLP such as steroids,
Cyclosporine and topical retinoid in a systematic review and concluded that there are only
weak evidence for the superiority of this treatment compared with placebo . The authors also
expressed several studies has been faced with restrictions in which various compounds with
potentially useful results on the OLP.
Conducted studies were not enough strong , the control group was small, making blind about
the researcher or patient didn't do in them or have been made errors in designing the study.
There would be special need to statistically powerful studies in order to determine the
value of new compounds in the prevention or treatment of mucositis .(17)
The purpose of this study is to find a way to reduce pain and inflammation in patients with
symptomatic OLP On the one hand and reduce the risk of infection, reduce the need for pain
medication and ultimately improve the quality of life by using triamcinolone mucoadhesive
films or licorice in this group of patients.
Methods and materials:
This study was a clinical trial and randomized as double-blind. Sampling was done randomly
Patients with symptomatic OLP who referred to the Oral Medicine School of Dentistryin
Medical Sciences in Isfahan University participated voluntarily.. In this study, patients
with symptomatic OLP over 18 years both men and non-pregnant women enrolled in the study and
. All patients were examined for dental Prophylaxis and oral hygiene and recommendations
about compliance with oral health have been done for all patients . After filling written
consent , the patients were divided into two groups randomly :first group I (n = 30) will be
treated with triamcinolone Mucoadhesive film and the second group (n = 30) will be treated
with licorice mucoadhesive film.
All patients underwent a complete dental examination and diagnosis of patients with oral
lichen planus lesions initially marked by physical examination and conducted by interviewing
with patients and then confirmed by histologic evaluation .The duration of treatment or
recovery of lesions was two weeks as the weekly visits.
The Triamcinolone Mucoadhesive film with 1 mg was prepared and provided to patients in one
group. And another group was given licorice mucoadhesive film by Afnogel brand name .The
drug dose was determined three times a day after meals and before bed time that patients put
it in the upper part of gum after eating and washing mouth and the patient can do common
function like talking and eating and drinking within releasing the drug.
Severity and recovery rate of lesions were measured in each visit in accordance with the
criteria that set in Buajeeb etal(18) from 0 to 5 degrees .The rate of pain in patients that
created by Mucositis assessed by ruler and VAS method and it was given a number from 0 to 10
according to the rate of pain.
Injury or burning ,pain on waking, eating, drinking, talking, pain when swallowing, dry
mouth, tingling or numbness after taking the studied medication and using the products
containing caffeine, tobacco, and alcohol in the questionnaire registered by the patient
.The compliance of patients were evaluated based on the returned mucoadhesive at the end of
each week and based on the number of patients' visits to physicians. The patient withdrew
from the study for any reason, pregnancy, drug interactions, compliance less than 70%
patients about taking the medicine o has been done by referring to the doctor .All of the
cases were collected and analyzed by the Mann-Whitney test.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05997173 -
The Regulatory Role of Immune Response in Oral Lichen Planus
|
||
Completed |
NCT02443311 -
Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus
|
Phase 4 | |
Completed |
NCT00484250 -
Study of Metronidazole and Doxycycline to Treat Oral Lichen Planus and to Compare Their Efficacy With Each Other
|
Phase 2 | |
Completed |
NCT03682562 -
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
|
||
Not yet recruiting |
NCT06428630 -
Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus
|
Early Phase 1 | |
Completed |
NCT04193748 -
Evaluation of Topical Pomegranate Extracts in Management of Oral Lichen Planus (A Randomized Clinical Trial)
|
Phase 4 | |
Completed |
NCT04153266 -
Oral Epithelial Dysplasia Informational Needs Questionnaire
|
||
Recruiting |
NCT06135805 -
Impact of Fluocinonide 0,05% in Oral Lichen Planus
|
N/A | |
Completed |
NCT04289233 -
Molecular & Cellular Characterisation of Oral Lichen Planus
|
||
Completed |
NCT04293718 -
Acquired Chronic Erosive Gingivitis: Clinical Relevance of Papillary Gingival Biopsy
|
||
Completed |
NCT00525421 -
A Clinical Study of Curcuminoids in the Treatment of Oral Lichen Planus
|
Phase 2 | |
Not yet recruiting |
NCT04091698 -
Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical Trial
|
Phase 1 | |
Completed |
NCT03386643 -
Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus
|
Phase 2 | |
Withdrawn |
NCT03836885 -
Apremilast - Oral Lichen Planus Trial
|
Phase 2 | |
Completed |
NCT05730855 -
Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions
|
||
Completed |
NCT03257228 -
The Association Between Diabetes Mellitus, Oral Lichen Planus and Insulin-like Growth Factors 1 and 2 (IGF1 and IGF2)
|
N/A | |
Recruiting |
NCT03026478 -
Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus
|
Phase 2 | |
Completed |
NCT02834520 -
Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus
|
N/A | |
Completed |
NCT02858297 -
Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus
|
Phase 4 | |
Completed |
NCT02106468 -
The Efficacy of Omega-3 in Treatment of Atrophic/Erosive Lichen Planus
|
Phase 2 |